Correlation Between Histogen and AN2 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Histogen and AN2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Histogen and AN2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Histogen and AN2 Therapeutics, you can compare the effects of market volatilities on Histogen and AN2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Histogen with a short position of AN2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Histogen and AN2 Therapeutics.
Diversification Opportunities for Histogen and AN2 Therapeutics
-0.65 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Histogen and AN2 is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Histogen and AN2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AN2 Therapeutics and Histogen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Histogen are associated (or correlated) with AN2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AN2 Therapeutics has no effect on the direction of Histogen i.e., Histogen and AN2 Therapeutics go up and down completely randomly.
Pair Corralation between Histogen and AN2 Therapeutics
Given the investment horizon of 90 days Histogen is expected to under-perform the AN2 Therapeutics. In addition to that, Histogen is 3.58 times more volatile than AN2 Therapeutics. It trades about -0.3 of its total potential returns per unit of risk. AN2 Therapeutics is currently generating about 0.21 per unit of volatility. If you would invest 110.00 in AN2 Therapeutics on August 29, 2024 and sell it today you would earn a total of 29.00 from holding AN2 Therapeutics or generate 26.36% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Histogen vs. AN2 Therapeutics
Performance |
| Timeline |
| Histogen |
| AN2 Therapeutics |
Histogen and AN2 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Histogen and AN2 Therapeutics
The main advantage of trading using opposite Histogen and AN2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Histogen position performs unexpectedly, AN2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AN2 Therapeutics will offset losses from the drop in AN2 Therapeutics' long position.| Histogen vs. PayPal Holdings | Histogen vs. Nasdaq Inc | Histogen vs. Choice Hotels International | Histogen vs. Microsoft |
| AN2 Therapeutics vs. Bright Minds Biosciences | AN2 Therapeutics vs. HP Inc | AN2 Therapeutics vs. Intel | AN2 Therapeutics vs. Chevron Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |